Rigorous trials suggest two drugs can reduce the risk of developing long-term health issues following a coronavirus infection. The findings, published on July 29, 2026, offer potential preventative measures against long COVID.
According to *Nature*, researchers have identified two drugs that demonstrate promise in preventing long COVID. These trials represent a significant step forward in addressing the ongoing challenges posed by the lingering effects of coronavirus infection.
The article states that these are “rigorous trials” suggesting the drugs reduce the risk of long-term disease after coronavirus infection. The specific names of the drugs and details about the trials themselves were not provided in the source material, but the findings indicate a potential pathway for preventative treatment.
The research is significant because long COVID continues to affect a substantial number of individuals post-infection, creating both individual health burdens and strain on healthcare systems. Identifying preventative measures could substantially reduce these impacts.
We don't rate truth. We strip the spin and show you which perspectives covered the story. You decide.
Read the original coverage
💬 Comments
📜 Comment Policy